Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biocon Ltd. Share Issue/Capital Change 2021

Apr 28, 2021

61176_rns_2021-04-29_79f1c21f-12bd-4d90-8b95-6cdf245cfffc.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

==> picture [132 x 52] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423 CIN: L24234KA1978PLC003417 www.biocon.com

April 28, 2021

April 28,2021 www.biocon.com
To,
The Manager
BSE Limited
Department of Corporate Services
Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai – 400 001
To,
The Manager
National Stock Exchange of India Limited
Corporate Communication Department
Exchange Plaza, Bandra Kurla Complex
Mumbai – 400 050
Scrip Code - 532523 Scrip Symbol – Biocon

Subject: Allotment of equity shares to Biocon India Limited Employee Welfare Trust under Biocon Restricted Stock Unit Long Term Incentive Plan FY 2020-24.

Ref: Regulation 10 (c) of SEBI (Share Based Employee Benefits) Regulations, 2014 (‘SEBI SBEB Regulations’) and Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

Dear Sir/Madam,

With reference to the captioned subject, we would like to inform you that the Board of Directors at its meeting held on April 28, 2021, has approved the allotment of 6,00,000 equity shares to Biocon India Limited Employee Welfare Trust under Biocon Restricted Stock Unit Long Term Incentive Plan FY 2020-24.

Consequent to the aforesaid allotment, the revised paid up equity capital of the Company is as below:

Particulars No. of Shares Face Value Amount in Rs.
Paid upEquityShare Capital(Pre-Allotment) 120,00,00,000 Rs. 5/- 600,00,00,000
Paid upEquityShare Capital(Post-Allotment) 120,06,00,000 Rs. 5/- 600,30,00,000

In terms of Regulation 10(c) of the SEBI SBEB Regulations, the details of shares allotted as above are given in Annexure A, enclosed herewith.

The above information will also be available on the website of the company at www.biocon.com.

Kindly take the above information on record and acknowledge.

Thanking You,

Yours faithfully,

For Biocon Limited

MAYANK Digitally signed by MAYANK VERMA VERMA Date: 2021.04.29 00:16:08 +05'30'


Mayank Verma Company Secretary and Compliance Officer

==> picture [132 x 52] intentionally omitted <==

Disclosure pursuant to Regulation 10(c) of SEBI SBEB Regulations

S. No. Particulars Details Details Details
1 Company name and address of
Registered Office
Biocon Limited,
20thKM, Hosur Road, Electronic City, Bengaluru,
Karnataka, 560100
2 Name of the Stock Exchanges on which
the Company’s shares are listed:
BSE Limited (‘BSE’)
National Stock Exchange of India Limited (‘NSE’)
3 Filing date of the statement referred in
regulation 10(b) of the SEBI (Share
Based Employee Benefits) Regulations,
2014 with Stock Exchange.
Name of Stock
Exchange
Filing Date Approval Date
BSE March 25, 2021 April 20, 2021
NSE March 24, 2021 April 12, 2021
4 Filing Number, if any BSE: DCS/FL/PB/ESOP-IP/1178/2021-22
NSE: NSE/LIST/26519
5 Title of the Scheme pursuant to which
shares are issued, if any.
Biocon Restricted Stock Unit Long Term Incentive Plan FY
2020-24.
6 Kind of security to be listed Equity shares
7 Par value of the shares Rs. 5/- each
8 Date of issue of shares April 28, 2021
9 Number of shares issued 6,00,000
10 Share Certificate No., if applicable NA
11 Distinctive number of the share, if
applicable
120,00,00,001 to 120,06,00,000
12 ISIN Number of the shares if issued in
Demat
INE376G01013
13 Exercise price per share: Rs. 5 per equity share
14 Premium per share: Nil
15 Total issued shares after this issue: 120,06,00,000
16 Total Issued share capital after this
issue:
Rs. 600,30,00,000
17 Details of any lock-in on the shares: NA
18 Date of expiry of lock-in NA
19 Whether shares identical in all respects
to existing shares if not, when will they
become identical? :
Equity shares allotted shall rank pari-passu with the
existing equity shares of the Company.
20 Details of listing fees, if payable: Listing fees has already been paid by the Company to the
respective stock exchanges.